Pineapple Express Cannabis (PNXP) EBITDA Margin (2018 - 2024)
Pineapple Express Cannabis (PNXP) has disclosed EBITDA Margin for 6 consecutive years, with 28.81% as the latest value for Q4 2024.
- Quarterly EBITDA Margin changed N/A to 28.81% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 15239.34% through Jul 2025, down 1515596.0% year-over-year, with the annual reading at 104.26% for FY2025, N/A changed from the prior year.
- EBITDA Margin hit 28.81% in Q4 2024 for Pineapple Express Cannabis, down from 43.48% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 546.58% in Q1 2021 to a low of 1684.78% in Q1 2022.
- Historically, EBITDA Margin has averaged 151.55% across 4 years, with a median of 3.87% in 2020.
- Biggest five-year swings in EBITDA Margin: soared 18125bps in 2021 and later plummeted -223136bps in 2022.
- Year by year, EBITDA Margin stood at 21.07% in 2020, then skyrocketed by 87bps to 39.5% in 2021, then tumbled by -1398bps to 512.79% in 2022, then soared by 94bps to 28.81% in 2024.
- Business Quant data shows EBITDA Margin for PNXP at 28.81% in Q4 2024, 43.48% in Q3 2024, and 184.11% in Q2 2024.